Verve Therapeutics Inc - Received First Milestone Payment From Eli Lilly for Collaboration on in Vivo Gene Editing Program Targeting Lipoprotein(a)
Verve Therapeutics Inc-因合作开展针对脂蛋白(a)的体内基因编辑计划而获得礼来公司的第一笔里程碑式付款
Verve Therapeutics Inc - Received First Milestone Payment From Eli Lilly for Collaboration on in Vivo Gene Editing Program Targeting Lipoprotein(a)
Verve Therapeutics Inc-因合作开展针对脂蛋白(a)的体内基因编辑计划而获得礼来公司的第一笔里程碑式付款
使用浏览器的分享功能,分享给你的好友吧